Skip to content

FDA Announces Label Change Indicating Regranex Risk

The U.S. Food and Drug Administration (FDA) has announced a boxed warning on the label of Regranex Gel (becaplermin) to address the increased risk of cancer deaths in patients who use 3 or more…

FDA Announces Label Change Indicating Regranex Risk
Published:

The U.S. Food and Drug Administration (FDA) has announced a boxed warning on the label of Regranex Gel (becaplermin) to address the increased risk of cancer deaths in patients who use 3 or more tubes of the product. Regranex is used for the treatment of leg and foot ulcers that are not healing correctly or at all in diabetic patients.

Ragranex is applied directly to diabetic foot and leg ulcers that aren’t healing. In a study completed in 2001, there were more deaths from cancer in people who used Ragranex than those who didn’t.

In this particular case, the drug manufacturer was aware of the potential cancer hazard in their product, and chose to monitor it closely prior to release. It is alarming to examine just how many drugs are out there whose side effects are potentially harmful or deadly. We have had several clients who ended up with severe adverse effects in using dangerous pharmaceuticals.Click here to learn more about drug injury and the legal process.

Tags: Health

More in Health

See all
Netflix Documentary Highlights Family’s CRPS Struggles

Netflix Documentary Highlights Family’s CRPS Struggles

/
Can Stem Cells Help Treat CRPS?

Can Stem Cells Help Treat CRPS?

/

More from The Legal Examiner

See all
Do I Have CRPS/RSD? How to Tell

Do I Have CRPS/RSD? How to Tell

/
Former ER Doctor Spreads the Word: CRPS is Real

Former ER Doctor Spreads the Word: CRPS is Real

/